Michael Wood | LifeSci Advisors |
Chaim Lebovits | President and CEO |
Stacy Lindborg | EVP and Chief Development Officer |
Ralph Kern | President and Chief Medical Officer |
Alla Patlis | Interim CFO |
David Bautz | Zacks Small-Cap |
Daniel Walker | Ness Industries |
Greetings, and welcome to the Brainstorm Cell Therapeutics Third Quarter 2022 Conference Call. At this time, participants are in a listen-only mode.
As a reminder, this conference call is being recorded.
And now, I would like to introduce your host for today's conference, Michael Wood of LifeSci Advisors. Mr.